Refractory / relapsed / progressive systemic sclerosis

Clinical trials for Refractory / relapsed / progressive systemic sclerosis explained in plain language.

Never miss a new study

Get alerted when new Refractory / relapsed / progressive systemic sclerosis trials appear

Sign up with your email to follow new studies for Refractory / relapsed / progressive systemic sclerosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

Engineered immune cells aim to tame stubborn autoimmune diseases

Disease control Not yet recruiting

This early-stage trial tests a one-time infusion of donor immune cells (CAR-γδT cells) designed to target and destroy faulty B cells in people with severe autoimmune diseases like lupus and scleroderma. The main goal is to check safety and find the right dose in 9 adults whose di…

Matched conditions: REFRACTORY / RELAPSED / PROGRESSIVE SYSTEMIC SCLEROSIS

Phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated Jun 27, 2026 13:04 UTC

Refractory / relapsed / progressive systemic sclerosis

Get alerted when new Refractory / relapsed / progressive systemic sclerosis trials appear

Engineered immune cells aim to tame stubborn autoimmune diseases